Skip to main content
. 2020 Sep 15;10:568417. doi: 10.3389/fonc.2020.568417

Table 5.

Multivariate subgroup analysis of 5-years OS, according to adjuvant chemotherapy and tumor sidedness.

5-years survival, % HR 95% CI P
Adjuvant chemotherapy (n = 8,985)
Left sided 73.4 Ref = 1
Right sided 73.5 1.04 0.94–1.15 0.4623
Transverse 74.1 0.96 0.83–1.13 0.6022
No adjuvant chemotherapy (n = 33,986)
Left sided 54 Ref=1
Right sided 54.6 0.92 0.88–0.96 <0.0001
Transverse 53.8 0.95 0.9–1.00 0.0677
Left sided
(n = 15,107)
No chemotherapy 54 Ref = 1
Chemotherapy 73.4 0.58 0.53–0.62 <0.0001
Right sided
(n = 23,151)
No chemotherapy 54.6 Ref = 1
Chemotherapy 73.5 0.6 0.56–0.65 <0.0001
Transverse
(n= 4,713)
No chemotherapy 53.8 Ref = 1
Chemotherapy 74.1 0.55 0.48–0.64 <0.0001